These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives. Ammirati E; Contri R; Coppini R; Cecchi F; Frigerio M; Olivotto I Eur J Heart Fail; 2016 Sep; 18(9):1106-18. PubMed ID: 27109894 [TBL] [Abstract][Full Text] [Related]
4. [Drug therapy of hypertrophic cardiomyopathy]. Hartmann A; Kaltenbach M; Hopf R Fortschr Med; 1992 Sep; 110(27):485-8. PubMed ID: 1358773 [TBL] [Abstract][Full Text] [Related]
5. Lifestyle Modification and Medical Management of Hypertrophic Cardiomyopathy. Heitner SB; Fischer KL Cardiol Clin; 2019 Feb; 37(1):45-54. PubMed ID: 30447715 [TBL] [Abstract][Full Text] [Related]
6. [Hypertrophic cardiomyopathy (HCM). Surgical versus drug therapy]. Schulte HD; Gramsch-Zabel H; Schwartzkopff B; Gams E Z Kardiol; 1999 Mar; 88(3):163-72. PubMed ID: 10355066 [TBL] [Abstract][Full Text] [Related]
7. Current and emerging pharmacotherapy for the management of hypertrophic cardiomyopathy. Rosenzveig A; Garg N; Rao SJ; Kanwal AK; Kanwal A; Aronow WS; Martinez MW Expert Opin Pharmacother; 2023; 24(12):1349-1360. PubMed ID: 37272195 [TBL] [Abstract][Full Text] [Related]
8. Impact of peak provoked left ventricular outflow tract gradients on clinical outcomes in hypertrophic cardiomyopathy. Lu DY; Hailesealassie B; Ventoulis I; Liu H; Liang HY; Nowbar A; Pozios I; Canepa M; Cresswell K; Luo HC; Abraham MR; Abraham TP Int J Cardiol; 2017 Sep; 243():290-295. PubMed ID: 28747034 [TBL] [Abstract][Full Text] [Related]
9. Aficamten: A Breakthrough Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy. Sebastian SA; Padda I; Lehr EJ; Johal G Am J Cardiovasc Drugs; 2023 Sep; 23(5):519-532. PubMed ID: 37526885 [TBL] [Abstract][Full Text] [Related]
10. Medical treatment of hypertrophic cardiomyopathy. Sherrid MV; Gunsburg D; Sharma A Curr Cardiol Rep; 2000 Mar; 2(2):148-53. PubMed ID: 10980886 [TBL] [Abstract][Full Text] [Related]
11. [Medical treatment for cardiomyopathies]. Suwa M Nihon Rinsho; 2000 Jan; 58(1):59-63. PubMed ID: 10885289 [TBL] [Abstract][Full Text] [Related]
12. Review of Mavacamten for Obstructive Hypertrophic Cardiomyopathy and Future Directions. Dong T; Alencherry B; Ospina S; Desai MY Drug Des Devel Ther; 2023; 17():1097-1106. PubMed ID: 37064432 [TBL] [Abstract][Full Text] [Related]
13. [Hypertrophic cardiomyopathy: which therapy? Comparison between beta blockers and calcium antagonists on the symptomatology and natural history of the disease]. Schiavoni G; Favuzzi A; Manzoli U Cardiologia; 1985 Apr; 30(4):265-9. PubMed ID: 2870803 [No Abstract] [Full Text] [Related]